Results 11 to 20 of about 617,524 (267)
Stem Cell Research, 2021 Recently, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has spread around the world and is receiving worldwide attention. Approximately 20% of infected patients are suffering from severe disease of multiple systems and in danger of death, while the ocular complications of SARS-CoV-2-infected patients have not been reported generally. Herein,
Li, Yan-Ping +3 more
openaire +3 more sources
Vaccine trials during a pandemic: potential approaches to ethical dilemmas
Trials, 2021 Ever since the emergence of the coronavirus disease 2019 (COVID-19), global public health infrastructures and systems, along with community-wide collaboration and service, have risen to an unprecedented challenge.
Manaf Alqahtani +3 more
doaj +1 more source
Vacunas (English Edition), 2020 It is hard to predict when vaccines against infection by SARSCoV-2 coronavirus may become available. The emergence of COVID-19 has led people to think that the best way of preventing it will be by using vaccines, as normally occurs when a new infectious disease appears.
Urbiztondo, L., Borràs, E., Mirada, G.
openaire +3 more sources
Vaccines, 2021 Background: Mucormycosis is a life-threatening invasive fungal infection most commonly observed in immunocompromised patients. Throughout the COVID-19 pandemic, a growing number of Mucorales associated infections, now termed COVID-19 associated ...
Elsa Yolanda Palou +13 more
doaj +1 more source
Cell & Bioscience, 2022 Background Thrombosis and coagulopathy are pervasive pathological features of coronavirus disease 2019 (COVID-19), and thrombotic complications are a sign of severe COVID-19 disease and are associated with multiple organ failure and increased mortality ...
Weiping Ji +9 more
doaj +1 more source
Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3–12 Years Old
Vaccines, 2022 Background and Objectives: In the current COVID-19 pandemic, children below the age of 12 could manifest COVID-19 symptoms and serve as a reservoir for the virus in the community.
Khaled Greish +13 more
doaj +1 more source
Revista Argentina de Salud Pública, 2021 INTRODUCCIÓN: En 2019, surgió un nuevo coronavirus que causó una pandemia mundial. Durante 2020, se desarrollaron vacunas con aceptable seguridad y eficacia para disminuir complicaciones y muertes.
Lucas Fernando de Candia +15 more
doaj
Comparison of COVID-19 Vaccination Rollout Approaches across Canada
Health Reform Observer - Observatoire des Réformes de Santé, 2023 Across Canada, there were notable differences in the rollout of provincial/territorial COVID-19 vaccination programs, reflecting diverse sociodemographic profiles, geopolitical landscapes, health system designs, and pandemic experiences.
Tiffany Fitzpatrick +7 more
doaj
eJHaem, 2021 Introduction Studies that examine the association between sickle cell disease (SCD) and COVID‐19 outcomes are lacking. This study aims to determine whether SCD is a risk factor for severe COVID‐19 infection in regard to the requirement of noninvasive ...
Abdulkarim Abdulrahman +7 more
doaj +1 more source
Epidemiological assessment of SARS-CoV-2 reinfection
International Journal of Infectious Diseases, 2022 Objectives: SARS-CoV-2 vaccination has been shown to reduce infection severity; however, the reinfection frequency among unvaccinated, partially vaccinated, and fully vaccinated individuals remains unclear.
Marwa Almadhi +6 more
doaj +1 more source